Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Combined With Ropivacaine in Brachial Plexus Block PK Study
ChiCTR-IPR-17010593Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and ropivacaine (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Ropivacaine concentration, Onset time of sensory block and 3 more. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
Beyond the preview
Go deeper on ChiCTR-IPR-17010593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010593.